ATM and non-small cell lung carcinoma: Western blot analysis confirmed that the two ATM biallelic mutant NSCLC PDX models with the highest degree of sensitivity to niraparib, i.e., LXFA 2155 (PDX#5) and LXFA 2184 (PDX#6), had no detectable ATM protein expression.